(Press-News.org) Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
This molecule is based on a natural protein present in human breast milk, which has been found to have strong and wide-ranging tumour killing properties when bound to certain lipids. Lipids are organic molecules like amino acids and carbohydrates, made up of carbon and hydrogen, and help to store energy and to form biological membranes.
The protein-lipid molecule complex, is known as HAMLET, which stands for Human Alpha-lactabumin Made Lethal to Tumour cells. It has been proven to be safe and effective as it only targets tumour cells, leaving healthy human cells intact.
HAMLET has most recently been shown to successfully suppress colon cancer in laboratory mice.
The scientists have also successfully identified and isolated specific components of HAMLET called peptide-oleate bound forms, which have the tumour-killing effect. Peptides are short chain amino acids commonly found in the human body.
These latest breakthroughs are led by Professor Catharina Svanborg and Dr Manoj Puthia from Lund University, Sweden, and Professor Gerhard Grüber from NTU's School of Biological Sciences. The HAMLET complex was first discovered by Professor Svanborg's research group.
The findings were published recently in Gut and in PLoS ONE, two top ranking peer-reviewed academic journals. The researchers found that laboratory mice genetically modified to develop colon cancer, were protected to a large extent when fed with HAMLET-laced water. This suggested that HAMLET was killing emerging tumour cells faster than these cells could grow and proliferate.
On the new concept of a synthetic version of the tumour-killing molecule, Prof Grüber said, "By studying the original protein, we have and will continue to identify key components to make a synthetic peptide, a short-chain amino acid, carrying the properties of HAMLET and yet more resilient than the original protein complex."
"By synthetically constructing the key components, this helps the peptide to be much more resilient and to 'survive' in different environments, such as in the human body or in drinking water, which is an ideal delivery medium, before it reaches its tumour target."
The ability to recreate HAMLET in synthetic form opens up possibilities of turning it into a drug to kill tumours.
Next steps|
Prof Svanborg, who is a doctor and a scientist, said she had seen promising results from the human trials using HAMLET in Sweden.
"We are now ready to test HAMLET as a therapeutic and preventive agent in colon cancer, especially in families with the genetic predisposition, where preventive options are limited," Prof Svanborg said.
"After completing the various clinical trials, we hope to develop a commercially available product for doctors' use for cancer treatment in the next five to ten years," she added.
The two lead scientists added that they are also looking to trial HAMLET in Singapore and are in talks with local institutions and industry.
INFORMATION:
Media contact:
Lester Kok
Assistant Manager
Corporate Communications Office
Nanyang Technological University
Tel: 6790 6804
About Nanyang Technological University
A research-intensive public university, Nanyang Technological University (NTU) has 33,500 undergraduate and postgraduate students in the colleges of Engineering, Business, Science, and Humanities, Arts, & Social Sciences. It has a new medical school, the Lee Kong Chian School of Medicine, set up jointly with Imperial College London.
NTU is also home to world-class autonomous institutes – the National Institute of Education, S Rajaratnam School of International Studies, Earth Observatory of Singapore, and Singapore Centre on Environmental Life Sciences Engineering – and various leading research centres such as the Nanyang Environment & Water Research Institute (NEWRI), Energy Research Institute @ NTU (ERI@N) and the Institute on Asian Consumer Insight (ACI).
A fast-growing university with an international outlook, NTU is putting its global stamp on Five Peaks of Excellence: Sustainable Earth, Future Healthcare, New Media, New Silk Road, and Innovation Asia.
Besides the main Yunnan Garden campus, NTU also has a satellite campus in Singapore's science and tech hub, one-north, and a third campus in Novena, Singapore's medical district.
For more information, visit http://www.ntu.edu.sg
New tumor-killer shows great promise in suppressing cancers
2013-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Doctors prescribe more analgesics to women than to men just for being female
2013-05-21
Regardless of pain, social class or age, a woman is more likely to be prescribed pain-relieving drugs. A study published in Gaceta Sanitaria (Spanish health scientific journal) affirms that this phenomenon is influenced by socioeconomic inequality between genders in the Autonomous Community in which the patient resides.
In 1999, a researcher at the University of Harvard, Ishiro Kawachi, observed that in the states of the USA with a larger proportion of women with a high social class, mortality in both genders was lower.
Inspired by Kawachi's studies, experts at the ...
Estimates reveal low population immunity to new bird flu virus H7N9 in humans
2013-05-21
The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was previously only found in birds. The findings have implications for planning the public health response to this pandemic threat.
The study used a new, high throughput method that allows blood samples to be analysed for antibodies to multiple human and animal influenza viruses at the same time and is easier to standardise than previous techniques. However, ...
Glaucoma drug can cause droopy eyelids
2013-05-21
BOSTON (May 21, 2013) – Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, dryness, changes in eye color and other side effects. Now a new study has found that these drugs also cause upper and lower eyelid drooping and other issues that can interfere with vision. The findings are described in PLOS ONE.
Researchers from the Massachusetts Eye and Ear performed multivariable analysis accounting for age, ...
Most elite athletes believe doping substances are effective in improving performance
2013-05-21
Most elite athletes consider doping substances "are effective" in improving performance, while recognising that they constitute cheating, can endanger health and entail the obvious risk of sanction. At the same time, the reasons why athletes start to take doping substances are to achieve athletic success, improve performance, for financial gain, to improve recovery and to prevent nutritional deficiencies, as well as "because other athletes also use them".
These are some of the conclusions of a study conducted by researchers from the Department of Physical and Sports Education ...
Finding a family for a pair of orphan receptors in the brain
2013-05-21
Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological diseases.
The results are published in the Proceedings of the National Academy of Sciences, Early Edition.
The human genome is littered with orphans: proteins that look like they will bind and respond to a hormone or a brain chemical, based on the similarity of their sequences to other proteins. However, scientists haven't figured out what each orphan's ...
People on higher incomes are happier with new knees
2013-05-21
Knee replacement surgery is a very common procedure. However, it does not always resolve function or pain in all the recipients of new knees. A study by Robert Barrack, MD and his colleagues from the Washington University School of Medicine wanted to determine if any socioeconomic factors were associated with less successful outcomes of knee replacement surgery. Their study, which appears in Clinical Orthopaedics and Related Research®, published by Springer, found that lower-income individuals reported higher levels of dissatisfaction and poorer function than those with ...
Common food supplement fights degenerative brain disorders
2013-05-21
Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older people experiencing memory impairment. Now a team headed by Prof. Gil Ast and Dr. Ron Bochner of Tel Aviv University's Department of Human Molecular Genetics have discovered that the same supplement improves the functioning of genes involved in degenerative brain disorders, including Parkinson's disease and Familial Dysautonomia (FD).
In FD, a rare genetic ...
Evaluating a new way to open clogged arteries
2013-05-21
CAMBRIDGE, MA -- Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments has drawbacks, including the risk of side effects.
A new study from MIT analyzes the potential usefulness of a new treatment that combines the benefits of angioplasty balloons and drug-releasing stents, but may pose fewer risks. With this new approach, a balloon is inflated in the artery for only a brief period, during which it releases a drug that prevents ...
Mayo Clinic: How gold nanoparticles can help fight ovarian cancer
2013-05-21
ROCHESTER, Minn. — Positively charged gold nanoparticles are usually toxic to cells, but cancer cells somehow manage to avoid nanoparticle toxicity. Mayo Clinic researchers found out why, and determined how to make the nanoparticles effective against ovarian cancer cells. The discovery is detailed in the current online issue of the Journal of Biological Chemistry.
"This study identifies a novel mechanism that protects ovarian cancer cells by preventing the cell death or apoptosis which should occur when they encounter positively charged nanoparticles," say the senior authors ...
Rice unveils method for tailoring optical processors
2013-05-21
HOUSTON -- (May 21, 2013) -- Rice University scientists have unveiled a robust new method for arranging metal nanoparticles in geometric patterns that can act as optical processors that transform incoming light signals into output of a different color. The breakthrough by a team of theoretical and applied physicists and engineers at Rice's Laboratory for Nanophotonics (LANP) is described this week in the Proceedings of the National Academy of Sciences.
Rice's team used the method to create an optical device in which incoming light could be directly controlled with light ...